Flagship Harbor Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-209
Closed -$9K 1821
2020
Q3
$9K Buy
209
+113
+118% +$3.88K ﹤0.01% 1375
2020
Q2
$3K Hold
96
﹤0.01% 1766
2020
Q1
$3K Hold
96
﹤0.01% 1591
2019
Q4
$4K Hold
96
﹤0.01% 1602
2019
Q3
$2K Hold
96
﹤0.01% 1710
2019
Q2
$2K Hold
96
﹤0.01% 1719
2019
Q1
$1K Buy
+96
New +$1.49K ﹤0.01% 1793

Other funds holding ZYME

Flagship Harbor Advisors's ZYME Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Zymeworks (ZYME) in Q4 2020, closing a stake of 209 shares — an estimated $9K sold.

Flagship Harbor Advisors first reported a position in ZYME in Q1 2019 and held it in 7 quarters. The position peaked at $9K in Q3 2020. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Zymeworks position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 209 Zymeworks shares in Q4 2020, an estimated $9K.
  • Flagship Harbor Advisors first reported a position in Zymeworks in Q1 2019 and held it in 7 quarters.
  • Flagship Harbor Advisors's Zymeworks position peaked at $9K in Q3 2020.
  • 138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.